Siddhesh Joshi (Editor)

Désiré Collen

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Name  Desire Collen

Role  Physician
Désiré Collen Dsir Collen Wikipedia

Education  Katholieke Universiteit Leuven
Books  Thrombolysis: Biological and Therapeutic Properties of New Thrombolytic Agents

Bell Ceremony celebrate inclusion of Delta Lloyd and Thrombogenics in BEL 20


Désiré, Baron Collen (born 21 June 1943) is a Belgian physician and chemist. He was born in Sint-Truiden, Belgium.

Contents

Education

Désiré Collen trendsknackbemedias26121337583jpg

He graduated as an M.D. at the Katholieke Universiteit Leuven in 1968 and obtained a PhD in chemistry in 1974.

Career

He started his career as in 1968-1971 as a Resident in Internal Medicine at the University Hospitals of the Katholieke Universiteit Leuven. Since 2002 he has been a professor at the Centre for Molecular en Vascular Biology, and he is also head of the VIB Département of Transgene Technology and Gene Therapy, K.U.Leuven. Together with professor Billiau he discovered Tissue plasminogen activator (tPA) in 1979. He is the founder of the Flemish biotech company Thromb-X.

Awards

  • 1984: Francqui Prize on Biological and Medical Sciences.
  • 1985: Louis-Jeantet Prize for Medicine, together with Luc Montagnier and Michael Berridge.
  • 2005: Interbrew-Baillet Latour Health Prize, together with Peter Carmeliet.
  • References

    Désiré Collen Wikipedia


    Similar Topics
    Sajan (1969 film)
    Putih Abu Abu dan Sepatu Kets
    Susan K Mashiko
    Topics
     
    B
    i
    Link
    H2
    L